We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Humana Ordered To Turn Over Docs In EpiPen Antitrust MDL

Law360 (June 12, 2018, 7:58 PM EDT) -- A Kansas federal judge on Monday ordered Humana Inc. to hand over within three weeks documents related to a multidistrict litigation accusing drugmaker Mylan NV of antitrust violations related to a surge in the price of its allergy treatment device, the EpiPen.

Purchasers of Mylan’s EpiPen, an epinephrine auto-injector, or EAI, first subpoenaed documents from Humana in December related to the market and competitive conditions for EAI devices, insurance coverage, rebate information, consumer costs, distribution and pharmaceutical supply chain, promotional materials and other documents related to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.